No Data
[Data Insights] Institutions Cut Holdings in Lithium Battery Supply Chain for Two Consecutive Days; Multiple Funds Intensely Battle Over AI Application Stocks
① Multiple institutions made significant sales of lithium battery concept stocks yesterday. Today, Tinci Materials, Tianmi Shares, Duofluoride, and Huasheng Lithium Battery were sold off by institutional investors. ② AI application stock 'Worth Buying' hit a 20cm price limit today, with one leading speculative trading seat purchasing RMB 1.26 billion and one quantitative trading seat buying RMB 38.7 million, while four institutions sold RMB 1.64 billion worth of shares.
Hong Kong-listed biopharmaceutical sector bucks the trend with a rise! Institutions say innovative drugs and Hang Seng Tech are leading the rebound.
① How does the end of the U.S. government shutdown specifically impact liquidity in the Hong Kong stock market? ② Why are the innovative drug and Hang Seng Tech sectors in Hong Kong stocks considered key beneficiaries under improved liquidity conditions?
ETF Market Review | The decline in the photovoltaic sector narrowed in the afternoon, with both the CSI New Energy ETF and the CSI Photovoltaic ETF Index Fund falling by 4%.
Gelonghui, November 12 | A-share market fluctuated throughout the day, with the Shanghai Composite Index closing down 0.07% and the ChiNext Index falling 0.39%. The photovoltaic industry chain and nuclear fusion concept led declines, while cultivated diamonds and super-hard materials saw significant pullbacks. The insurance, pharmaceutical, and banking sectors performed strongly, with Agricultural Bank of China and ICBC both hitting new highs; ABC's market capitalization exceeded RMB 3 trillion. In the ETF sector, innovative drug stocks rebounded across the board, with Harvest Fund’s S&P Biotech ETF, YinHua Fund’s Hong Kong Stock Connect Innovative Drug ETF, and HuiTianFu Fund’s Hong Kong Stock Connect Innovative Drug ETF rising 3.61%, 3.14%, and 3.1%, respectively. The Hong Kong stock dividend sector continued its recent upward trend.
Express News | The recovery trend in the pharmaceutical sector is gradually becoming evident, with the Hang Seng Innovative Drug ETF once rising over 3%.
Guosen Securities H Shares 2026 Investment Strategy: Focus on AI Application Trends and Grasp the PPI-CPI Rotation Rhythm
The sensitive time window for the expected slowdown in AI investment is from the second half of 2026 to the first quarter of 2027. Overall, technology sector earnings are projected to remain robust in 2026, but caution is warranted regarding potential temporary disruptions caused by an unemployment rate exceeding 4.5%. Gold and US equities are expected to outperform US bonds and cash.
ETF Market Wrap | Innovative drug sector surges against the trend! Huitianfu’s Sci-Tech Innovative Drug ETF and Guotai’s Sci-Tech Innovative Drug ETF soar over 7%.
Gelonghui, October 31 | The A-share market fell across the board today. The Shanghai Composite Index closed down 0.81%, but gained 1.85% in October and briefly surpassed the 4,000-point level; the Shenzhen Component Index dropped 1.14%, with a cumulative decline of 1.1% in October; and the ChiNext Index fell 2.31%, with a cumulative drop of 1.56% in October. The total turnover of the Shanghai, Shenzhen, and Beijing stock exchanges amounted to RMB 2.3498 trillion today, representing a decrease of RMB 114.5 billion compared to the previous day. More than 3,700 stocks in the entire market rose against the trend. The hardware supply chain for computing power saw significant pullbacks, with declines led by CPO and memory sectors. Semiconductor, consumer electronics, and rare earths also experienced notable losses. Meanwhile, AI applications, innovative drugs, and broad consumption concepts showed resilience.